1. Piramal Pharma
Piramal Pharma Share Price

Piramal Pharma Share Price

NSE: PPLPHARMA

|

BSE: 543635

|

Pharmaceuticals

100% Buy

₹194.29

-₹0.81 (-0.42%) Last updated on 23 Jun, 2025 | 15:58 IST

Piramal Pharma Overview

Market cap
Market Cap Switch₹25,845 Crs
Open
₹193.70
Prev. Close
₹195.10
Circuit range
₹214.61 - ₹175.59
Day range
₹192.49 - ₹195.62
Year range
₹145.25 - ₹307.90
Volume
14,36,059
Avg. traded
₹194.16
Revenue (12m)
₹9,151 Crs

About Piramal Pharma

Piramal Pharma Limited is a pharmaceutical company offering a portfolio of differentiated products and services through its global distribution network. Part of Piramal Group, the company has 17 global facilities with a network expanding in more than 100 countries. Piramal Group's presence in the pharma business goes back to 1988. It entered the space with the acquisition of Nicholas Laboratories in 1988. Over the years it transformed into the Piramal Healthcare network. In 2010, the pharma arm of Piramal Group sold the domestic formulations business to Abbott and diagnostic services to Super Religare Laboratories. Piramal Pharma then became part of Piramal Enterprises Limited.

Business operations

Piramal Pharma Solutions (PPS) and Piramal Critical Care (PCC) are subsidiaries of the company. PPS is the contractor development and manufacturing organisation (CDMO) under PPL, looking after end-to-end development and manufacturing solutions across the drug lifecycle.

Piramal Critical Care’s complex hospital product portfolio offers anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and other critical therapies. Its manufacturing facilities in the US and India have cleared periodic inspections by the US FDA, UK MHRA and other regulators.

The company sells its over-the-counter products like Lacto Calamine, I-Pill, Polycrol and Tetmosol through India Consumer Healthcare (ICH).

Piramal Pharma Limited was incorporated as a public firm in 2020. The company acquired the pharmaceutical business from Piramal Enterprises Limited. It received a growth equity investment from Carlyle Group Limited in the same year.

Piramal Pharma acquired a 100% stake in Convergence Chemicals Private Limited (CCPL). It also announced an expansion for antibody-drug conjugates at its Grangemouth (UK) facility and the drug substance capabilities at its Riverview facility (USA). The next year, the company acquired Hemmo Pharmaceuticals Private Limited (HPPL). The pharmaceutical business of Piramal Enterprises Limited (PEL) was demerged to PPL. The company's wholly-owned subsidiaries CCPL and HPPL were amalgamated into the firm.

Piramal Pharma has a joint venture, Allergan India Private Limited, with Allergan(now AbbVie), a key player in ophthalmology in the Indian market. It holds 49% of the paid-up capital in this venture. The company also has a minority stake of 33.33% in Yapan Bio, a company operating in the biologics/ bio-therapeutics and vaccine segments.

Piramal Pharma was listed on the Indian stock market in 2022. In FY 2023, the company launched its e-commerce website weelify.in to consolidate its presence in the e-commerce space.

Piramal Pharma’s market capitalisation stood at nearly ₹18,800 crore as of January 12, 2024. Piramal Pharma share price has moved up by 22.4% in the last one year.

Financial highlights

⦁ Piramal Pharma’s total revenue from operations in FY23 was ₹7,081.55 crore, a 7.9 % year-on-year growth from ₹6,559.1 crore in the last financial year. ⦁ The company reported a net loss of ₹186.46 crore in FY23 as against a profit of ₹ 375.9 crore in FY22. ⦁ EBITDA (earnings before interest, taxes, depreciation and amortisation) stood at ₹853.3 crore in FY23 as against ₹1,225.46 crore in FY22, marking a 30.36 % decline year-on-year. ⦁ Its basic earnings per share (EPS) slipped to a negative ₹1.57 in FY23 from ₹3.19 in the last financial year.

  • Chart
  • Fundamentals
  • Financials
  • F&O
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Piramal Pharma Share Price Chart

Please wait...

Piramal Pharma Key Indicators

P/E ratio
282.75
P/B ratio
3.4
ROE
6.55%
ROCE
8.33%
Dividend yield
0.07%
Debt/Equity ratio
0.17
EPS
2.96

Investment Checklist: (2/6)

passed

Equity returns

not passed

Dividend returns

not passed

Safety factor

NA

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Buy

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 9 experts in the last 7 days

Piramal Pharma Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

17.82%

Net profit margin

8.5%

ROE

6.55%

ROA

4.3%

ROCE

8.33%

Piramal Pharma Shareholder returns

1 day
+1.60%
1 week
-2.56%
1 month
-5.19%
3 months
-11.84%
1 year
+25.66%
3 years
+2.68%
5 years
+2.68%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-24
8,171.16
1,371.65
17.82
Mar-23
7,081.55
853.35
-186.46
Mar-22
6,559.10
1,225.46
375.96
Mar-21
6,314.90
1,592.07
835.03

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-24
1,004.54
-434.01
-422.36
Mar-23
483.89
-1,338.78
817.79
Mar-22
766.42
-1,812.1
794.19
Mar-21
597.58
-4,479.93
3976.83

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
15,297.24
7,385.87
Mar-23
14,436.54
7,663.04
Mar-22
12,717.19
6,020.59
Mar-21
10,756.08
5,151.08

Piramal Pharma Share Price History

DayOpenCloseChange %
20-Jun-25
₹192.49
₹195.10
+1.60%
19-Jun-25
₹193.80
₹192.03
-0.69%
18-Jun-25
₹193.00
₹193.37
-0.97%
17-Jun-25
₹199.49
₹195.26
-2.00%
16-Jun-25
₹200.92
₹199.25
-0.48%
13-Jun-25
₹197.00
₹200.22
+0.15%
12-Jun-25
₹205.48
₹199.93
-2.23%
11-Jun-25
₹207.07
₹204.50
-0.76%

Piramal Pharma Shareholding Pattern

CategoryDec 2024Sep 2024Jun 2024Mar 2024
Promoters
34.95%
34.95%
34.95%
35.02%
Foreign institutions-FII
31.68%
31.73%
31.41%
30.58%
Other domestic institutions
2.44%
2.59%
2.84%
3.12%
Retail and other
19.27%
19.52%
20.69%
22.26%
Mutual Funds
11.66%
11.21%
10.12%
9.01%

Corporate Actions

  • Dividend • ₹0.11/share

    Ex date 12 Jul 2024

    expand tab
  • Rights Issue • 5:46

    Ex date 02 Aug 2023

    expand tab

Popular Stocks

PriceNo Sort
Change %No Sort
IDFC First Bank₹71.01+₹0.82 (1.17%)
Indian Railway Finance Corp₹136.98+₹2.78 (2.07%)
ITC₹413.90-₹4.65 (-1.11%)
JIO FIN SERVICES LTD₹293.15-₹1.10 (-0.37%)
Reliance₹1,456.80-₹9.40 (-0.64%)
Suzlon₹62.79-₹0.44 (-0.7%)
Tata Motors₹671.25-₹4.95 (-0.73%)
Tata Power₹393.00+₹2.90 (0.74%)
Tata Steel₹152.43+₹0.46 (0.30%)
YES Bank₹19.88+₹0.15 (0.76%)

FAQs on Piramal Pharma

What is the share price of Piramal Pharma today?

chevron-up
Piramal Pharma share price is ₹ 194.29 as on 23 Jun, 2025 | 15:58 IST.

What are the high & low stock price of Piramal Pharma today?

chevron-up
Piramal Pharma stock price hit a high of ₹ 195.62 and low of ₹ 192.49 as on 23 Jun, 2025 | 15:58 IST.

What is the market cap of Piramal Pharma?

chevron-up
The market cap of Piramal Pharma is ₹ 25,844.78 Crores as on 23 Jun, 2025 | 15:58 IST.

What are the the 52-week high and low share prices of Piramal Pharma stock on the NSE?

chevron-up
52-week high stock Price of Piramal Pharma is ₹ 307.90 and Low Price is ₹ 145.25 as on 23 Jun, 2025 | 15:58 IST.

What are the stock symbols of Piramal Pharma?

chevron-up
The stock symbol of Piramal Pharma is NSE: PPLPHARMA on the NSE, BSE: 543635 on the BSE, and the ISIN is INE0DK501011.

Can I buy Piramal Pharma shares on Holidays?

chevron-up
No, shares of Piramal Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Piramal Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Piramal Pharma?

chevron-up
The PE and PB ratio of Piramal Pharma is 282.75 and 3.4 respectively, as on 23 Jun, 2025 | 15:58 IST.

What are the returns on Piramal Pharma shares?

chevron-up
The historical returns for Piramal Pharma shares are 25.66 for 1 year, 2.68 for 3 year and 2.68 for 5 year.